15 years of advances in egfr mutant lung cancer
Published 3 years ago • 2.2K plays • Length 58:47Download video MP4
Download video MP3
Similar videos
-
24:42
mechanisms of lung tumorigenesis by mutant egfr
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
1:01:28
translational lung cancer research at yale: 10 years-in-review
-
54:40
smilow shares primary care: lung cancer
-
3:38
overview of the world of egfr mutant lung cancers
-
24:58
strategies to prevent and overcome resistance to egfr-directed therapies in lung cancer
-
27:37
next generation egfr inhibitors for mutations and disease
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
0:48
current role of immunotherapy in egfr-mutant lung cancer
-
44:45
yale cancer center grand rounds/john murren lecture
-
1:05
dr. wakelee on recent advancements in egfr-mutant nsclc
-
1:18:11
management of egfr-mutant lung cancer with central nervous system metastases
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
14:24
egfr-mutant lung cancer & treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
1:01:43
yale cancer center grand rounds | october 6, 2023
-
3:14
dr. roy herbst, yale cancer center/smilow cancer hospital
-
5:02
egfr-mutant lung cancer: initial approach